People: Lonza Group AG (LONN.VX)

LONN.VX on Virt-X Level 1

108.30CHF
24 Oct 2014
Price Change (% chg)

CHF-0.80 (-0.73%)
Prev Close
CHF109.10
Open
CHF109.00
Day's High
CHF109.30
Day's Low
CHF107.60
Volume
173,960
Avg. Vol
199,934
52-wk High
CHF118.60
52-wk Low
CHF77.45

Search Stocks

Summary

Name Age Since Current Position

Rolf Soiron

69 2012 Chairman of the Board of Directors

Richard Ridinger

56 2012 Chief Executive Officer an Member of the Executive Committee

Peter Wilden

57 2013 Vice Chairman of the Board of Directors

Toralf Haag

48 2005 Chief Financial Officer, Member of the Executive Committee

Marc Funk

54 2014 Member of the Management Board, Chief Operating Officer, Chief Legal Officer

Sven Abend

2014 Member of the Executive Committee

Beat In-Albon

62 2012 Member of the Executive Committee, COO Life Science Ingredients division

Patrick Aebischer

60 2008 Member of the Board of Directors

Werner Bauer

64 2013 Member of the Board of Directors

Thomas Ebeling

55 2013 Member of the Board of Directors

Jean-Daniel Gerber

68 2011 Member of the Board of Directors

Margot Scheltema

60 2012 Member of the Board of Directors

Antonio Trius

59 2013 Member of the Board of Directors

Dirk Oehlers

IR Contact Officer

Biographies

Name Description

Rolf Soiron

Dr. Rolf Soiron has been Chairman of the Board of Directors of Lonza Group AG since April 11, 2005. He is Member of the Nomination and Compensation Committee of the Company. From January 24, 2012 to April 30, 2012, he waas also Interim Chief Executive Officer of the Company. From 2003 to 2010, he served as Chairman of the Board of Directors of Nobel Biocare Holding Ltd. He has been Member of the Board of Directors of Holcim Ltd, since 1994, and its Chairman since 2003. He has been Member of the Board of Directors of Jungbunzlauer Group since 1993. He served as Managing Director of Jungbunzlauer Group from 2001 till 2003. He served as Chief Executive Officer of Jungbunzlauer Group from 1993 till 2001. He served as Chief Operating Officer and Head of Pharma at Sandoz Group, from 1992 till 1993, and as Group Vice-President Agribusiness USA from 1988 till 1992. He acted as President and Chief Executive Officer of Protek Group from 1983 till 1987. He held various functions in Human Resources, Finance and Corporate at Sandoz Group from 1982 till 1983. He has been Chairman of the Foundation Council of Avenir Suisse since 2009. Furhermore, he has been Member of the International Committee of the Red Cross since 2009. He has been Member of the Board of economiesuisse since 2009. He has served as Chairman of the Basel University Council from 1995 till 2005. He is Accredited Business Accountant. He holds a Doctorate in Philosophy in History from Universitaet Basel, obtained in 1972, and a Professional Masters Degree (PMD) from Harvard Business School.

Richard Ridinger

Mr. Richard Ridinger has been Chief Executive Officer an Member of the Executive Committee of Lonza Group AG since May 1, 2012. He holds a degree in chemical engineering from Universitaet Karlsruhe. His former activities include Member of the Management Board and Executive Vice-President Care Chemicals at Cognis GmbH from 2006 to 2010 and Transfer and integration of Cognis GmbH into BASF (2011), SBU Head of 'Cognis Care Chemicals' and member of the Cognis Executive Committee (2002 - 2006), Vice-President of the global 'Care Chemicals Specialties' business of Cognis GmbH (2000 - 2002), Director global Skin Care Ingredients Business at Henkel KGaA / Cognis GmbH (1999 - 2000), and various positions at Henkel KGaA (1986 - 1999).

Peter Wilden

Mr. Peter Wilden has been Vice Chairman of the Board of Directors at Lonza Group AG. He was appointed Member of the Board of Directors of the Company in March 2004. He is Chairman of the Audit and Compliance Committee at the Company. Currently, he serves as Executive Vice-President Finance and Chief Financial Officer of Ferring Pharmaceuticals in Lausanne, as well as Member of various scientific research organizations in Germany, the United States and the Netherlands. Prior to that, he served as Member of the Board of Trace Biotech AG, Consultant for Mak Data System, Management Assistant with Krupp MaK Maschinenbau GmbH and Scientific Assistant of the Kiel Institute of World Economics, among others. He holds a Doctorate in Philosophy degree in Business Administration from Christian-Albrechts-Universitaet zu Kiel (University of Kiel) and a degree in Business Administration and Information Technology.

Toralf Haag

Mr. Toralf A. Haag has been Chief Financial Officer and Member of the Executive Committee of Lonza Group AG since August 2005. He served as Chief Financial Officer and Member of the Management Board at Norddeutsche Affinerie AG from 2002 to 2005. Prior to that, he acted as Chief Executive Officer (President) Stamping & Frame Division of The Budd Company Detroit from 2000 till 2001 and as Director Finance, M&A (Mergers and Acquisitions) and Corporate Development, at The Budd Company Detroit from 1997 to 1999. Between 1994 and 1996, he served as Assistant to the Chief Executive Officer of Thyssen Handelsunion AG. He graduated from Christian-Albrechts-Universitaet zu Kiel with a Doctorate in Philosophy degree and from Universitat Augsburg with a degree in Business Administration. Since 2012, Mr. Haag has also served as Member of the Board of scienceindustries, and since 2009 - as Member of the Board of Vereinigung Schweizer Finanzchefs (VSF).

Marc Funk

Mr. Marc Funk has been be appointed as Chief Operating Officer effective July 1, 2014 and would continue as Member of the Executive Committee and Chief Legal Officer of Lonza Group AG, the positions he has held since April 28, 2014. He has been with the Company since March 2011, when he took the position of Group General Counsel and Board Secretary. Prior to Lonza, Mr. Funk was General Counsel of GeneProt from 2000 to 2004, and Associate General Counsel of Merck Serono from 2004 to 2008. He holds a Master of Law from Universite de Geneve and a Master of Law and Diplomacy from the Fletcher School (Tufts University MA).

Sven Abend

Mr. Sven Abend has been appointed as Member of the Executive Committee of Lonza Group Ltd., effective July 1, 2014. He will have primary responsibility for Corporate Strategy and Business Development, as well as Consumer Care and Industrial Solutions, and will ensure focused delivery of Lonza's growth strategy. Sven Abend received his Ph.D. in Chemistry from the Christian-Albrechts-Universität in Kiel, Germany, and worked on his post-doctorate at the State University of New York in Stony Brook, New York (USA). He began his career as a scientist with Unilever's Home & Personal Care division. After moving to Cognis, he rapidly advanced into positions of broader and increasing responsibilities, including roles in product and portfolio management and global key account management. At Kolb he was appointed as CEO in 2012.

Beat In-Albon

Dr. Beat In-Albon has been Member of the Executive Committee and COO Life Science Ingredients division of Lonza Group AG since June 2012. He was previously Member of the Management Board of the Company from 1999 to 2006. Since June 2003, he has been Head of the Organic Fine and Performance Chemicals division. He joined the Company in 1983 and held various managerial positions with Lonza Ltd. in Basel. He holds Doctorate in Philosophy in Economics (1983) and an MBA in Political Economy (1978) from Universite de Fribourg.

Patrick Aebischer

Mr. Patrick Aebischer has been Member of the Board of Directors at Lonza Group AG since March 26, 2008. He is Member of the Innovation and Technology Committee at the Company. Since 2000, Mr. Aebischer has been the President of the Swiss Federal Institute of Technology (EPFL) in Lausanne and Professor of Neurosciences at EPFL. In addition, he has been Fellow of the American Institute for Medical and Biological Engineering since 2000. He also acted as Fellow of the Swiss Academy of Medical Sciences since 1998. He is Founder of three biotechnology companies. He holds a Doctorate in Medicine from Universite de Geneve. He has received numerous honors, including the Robert Bing Prize of the Swiss Academy of Medical Sciences and the Pfizer Foundation Prize for Clinical Neurosciences.

Werner Bauer

Prof. Dr. Werner J. Bauer has been Member of the Board of Directors at Lonza Group AG since April 2013. he is also Member of Innovation and Technology Committee. He holds a diploma and PhD in Chemical Engineering from the University Erlangen-Nuernberg. He has received several scientific honors, among others, such as the BioAlps Award 2011 and the Honorary Senator from the Technical University of Munich. He is Member of the Supervisory Board of Bertelsmann SE & Co. KGaA (since 2012) and Chairman of the Board of Trustees of the Bertelsmann Foundation (since 2011), Member of the Supervisory Board of GEA-Group AG (since 2011), Member of the Board of Directors of Galderma Pharma (since 2011), Member of the Supervisory Board of Nestlé Deutschland AG (since 2007). During his professional career, he was Head of Innovation, Technology, Research and Development of Nestle S.A. (2007–August 2013), Executive Vice-President of Nestle S.A. (2002–2007). He also held various managerial positions of increasing responsibility at Nestle (1990–2002), Director of the Fraunhofer Institute for Food Technology & Packaging (1985–1990), Professor of Chemical Engineering at the Technical University of Hamburg (1980–1985).

Thomas Ebeling

Mr. Thomas Ebeling has been Member of the Board of Directors at Lonza Group AG since April 2013. Currently, he is also Member of the Supervisory Board of Bayer AG (since 2012), Advisor to TPG Biotech Fund (since 2011), Chief Executive Offier of ProSiebenSat1. Media AG (since 2009). Prior to this, he was Chief Executive Officer of the Novartis Consumer Health Division (2007–2008), Chief Executive Officer of the global Novartis pharmaceuticals business (2000–2007), Head of Novartis Nutrition Division (1998–2000), General Manager of Novartis Nutrition for Germany and Austria (1997–1998). He holds a Master’s degree in Psychology from the University of Hamburg (Universitat Hamburg).

Jean-Daniel Gerber

Mr. Jean-Daniel Gerber has been Member of the Board of Directors at Lonza Group AG since April 2011. He is Member of the Audit and Compliance Committee at the Company. Prior to that, he acted as Director of the State Secretariat for Economic Affairs (SECO) with the title of State Secretary from 2004 to 2011. He was also Director of the Federal Office for Migration (then Federal Office for Refugees) in the Federal Department of Justice and Police between 1997 and 2004. From 1993 to 1997 he acted as Executive Director at the World Bank and Dean of the Executive Directors of the World Bank Group from 1996 to 1997. Between 1991 and 1992, Mr. Gerber acted as Chief of Section for Developing Countries in the former Federal Office for Foreign Economic Affairs. He holds a lic. rer. pol in Economics from Universitaet Bern. He was also awarded an honorary doctorate by the Faculty of Economics and Social Sciences of Universitaet Bern.

Margot Scheltema

Ms. Margot Scheltema has served as Member of the Board of Directors of Lonza Group AG since April 1, 2012. She is Member of the Audit and Compliance Committee of the Company. Ms. Scheltema holds a doctorate in international law from Universiteit van Amsterdam and a master of international affairs (MIA) from Columbia University in New York. She also serves as Member of the Supervisory Board of Warmtebedrijf Rotterdam, Member of the Supervisory Board of TNT Express, Vice-Chair of Triodos Bank’s Supervisory Board, and Member of the Supervisory Board of ASR NV, among others.

Antonio Trius

Dr. Antonio Trius has been Member of the Board of Directors of Lonza Group AG since April 2013. He is also Member of the Audit and Compliance Committee. He is Member of the Board of Directors of Azelis SA (since February 2014), Member of the Supervisory Board of Altana AG (since 2012), Member of the Board of Directors of Nubiola SL (since 2011). During his professional career, he was also Chief Executive Officer of Cognis GmbH (2001–2010), Executive Vice President Care Chemicals North America (1999–2001) and Vice President Care Chemicals at Henkel KGaA (1997–1999). He holds a Bachelor in Organic Chemistry from the University of Barcelona, a PhD in Chemistry from the Autonomous University of Barcelona and a PDD in Business Administration from the IESE Barcelona.

Dirk Oehlers

Basic Compensation

Name Fiscal Year Total

Rolf Soiron

461,488

Richard Ridinger

--

Peter Wilden

321,146

Toralf Haag

--

Marc Funk

--

Sven Abend

--

Beat In-Albon

--

Patrick Aebischer

240,865

Werner Bauer

193,477

Thomas Ebeling

--

Jean-Daniel Gerber

297,297

Margot Scheltema

280,068

Antonio Trius

196,684

Dirk Oehlers

--
As Of 30 Dec 2013
Search Stocks